Skip to main content
Equibles

Robert J. DelAversano

Chief Accounting Officer

Grace Therapeutics, Inc. (GRCE)

CFO

Grace Therapeutics, Inc. (GRCE)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Robert J. DelAversano

Robert J. DelAversano is recorded as Chief Accounting Officer and CFO at Grace Therapeutics, Inc. (GRCE). Grace Therapeutics, Inc. reported in an 8-K filed January 8, 2024 that Robert J. DelAversano was appointed principal accounting officer, effective January 5, 2024. Grace Therapeutics, Inc. reported in an 8-K filed January 8, 2024 that Robert J. DelAversano was appointed principal financial officer, effective January 5, 2024.

“On January 5, 2024, the Board of Directors (the "Board") of Acasti Pharma Inc. (the "Company") approved the appointment of Robert J. DelAversano, the Company's Vice President, Finance, to the roles of principal financial officer and principal accounting officer of the Company, effective immediately.”
Grace Therapeutics, Inc. Form 8-K, filed January 8, 2024 · Read the filing
“On January 5, 2024, the Board of Directors (the "Board") of Acasti Pharma Inc. (the "Company") approved the appointment of Robert J. DelAversano, the Company's Vice President, Finance, to the roles of principal financial officer and principal accounting officer of the Company, effective immediately.”
Grace Therapeutics, Inc. Form 8-K, filed January 8, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Grace Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.